Information on the Target
EG has successfully acquired the Danish software company Aver & Lauritzen ApS, thereby adding an additional medical system to its portfolio. This acquisition strengthens EG's position as a specialized software provider for the primary sector, particularly for general practitioners and specialists.
Mikkel Bardram, CEO of EG A/S, emphasized, "With Aver & Lauritzen on board, we can enhance the primary sector in Denmark and ultimately ensure better patient care pathways." He further noted the increasing demands from customers and authorities for software providers to meet higher standards.
Industry Overview in Denmark
The healthcare IT sector in Denmark is characterized by rapid technological advancement and increasing regulatory demands. As a leader in the provision of tailored software solutions for healthcare practitioners, EG Healthcare's recent growth, particularly the acquisition of Aver & Lauritzen, reflects a commitment to addressing the evolving needs of the primary healthcare system.
Denmark's primary healthcare system is undergoing significant transformation, driven by digitalization and new legislative frameworks aimed at enhancing patient care and operational efficiency. The government is implementing more stringent requirements for software vendors, necessitating innovation and compliance with emerging standards.
In this context, the demand for interoperable health IT solutions is rising, with new certifications and coding standards being introduced to ensure seamless communication between healthcare providers. Initiatives such as Fast Healthcare Interoperability Resources (FHIR) are being prioritized in efforts to achieve these standards.
EG Healthcare is well-positioned in this sector, with established solutions like EG Clinea and EG WinPLC already servicing over 1,100 clinics, indicating a strong market presence. The integration of Aver & Lauritzen's GANGLION system further enhances their offerings in this competitive landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The acquisition of Aver & Lauritzen is driven by EG's strategic goal to consolidate its role as a leading provider of healthcare software in Denmark. By expanding its portfolio with the GANGLION system, EG is poised to offer enhanced capabilities that meet the regulatory demands and innovative needs of the healthcare industry.
The integration of Aver & Lauritzen allows for shared expertise in developing comprehensive software solutions, which will facilitate a robust response to increasing competitive pressures and the need for innovation within the sector.
Information About the Investor
EG A/S is a prominent provider of sector-specific software, employing over 1,500 staff across the Nordic region and a joint development center in Poland. The company develops, delivers, and maintains software for more than 21,000 clients in both the private and public sectors.
EG has a history of making significant investments in healthcare technology, with notable acquisitions, including A-Data in 2020, which underscores its commitment to strengthening its healthcare division. This strategic direction illustrates EG's aim to leverage technology to enhance operational efficiencies across various sectors.
View of Dealert
From an analytical perspective, the acquisition of Aver & Lauritzen appears to be a strategic and potentially lucrative investment for EG. The growing regulatory requirements in the Danish healthcare sector create a robust demand for advanced IT solutions that can facilitate better patient care.
Moreover, Aver & Lauritzen's established product, GANGLION, complements EG's existing software range and addresses the critical need for innovative health IT solutions. This synergy positions EG to better meet the expectations of both clients and regulatory bodies, enhancing their competitive stance in the market.
Furthermore, with the expected integration of new functionalities and the ongoing development of software solutions, EG is likely to drive improvements in service delivery for the healthcare practitioners they serve. This proactive approach to innovation can lead to increased client satisfaction and retention.
In conclusion, given the strong alignment of Aver & Lauritzen's offerings with the market's evolving needs and EG's strategic growth objectives, this acquisition is well-aligned with EG's vision and promises significant growth opportunities in the future.
Similar Deals
Karo Healthcare → Perrigo’s Dermacosmetics portfolio
2026
Patient Square Capital → Premier Inc.
2026
EG A/S
invested in
Aver & Lauritzen ApS
in 2021
in a Buyout deal